New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 4, 2014
10:22 EDTNUS, USNA, HLFNu Skin retreats despite stronger than expected pre-announcement
Shares of multi-level-marketing company Nu Skin (NUS) are falling, even though the company pre-announced stronger than expected fourth quarter results. WHAT'S NEW: Nu Skin estimated that its fourth quarter earnings per share would be $2-$2.02, versus analysts' consensus estimate of $1.91. The company estimated that its fourth quarter revenue would be $1.08 billion, which is slightly above expectations. Nu Skin stated that it was rescheduling its full earnings release and conference call until later this month, due to the company's ongoing review of its business in China and its desire to provide the most informed guidance possible. Nu Skin launched the review of its China business last month after Chinese regulators began probing the company. The Chinese government began an investigation into allegations, first raised by a Chinese newspaper, that Nu Skin operates an illegal pyramid scheme in the country. WHAT'S NOTABLE: Herbalife (HLF), like Nu Skin, also distributes personal care and nutritional products and operates in China. A Chinese media report last August suggested that Herbalife may be violating Chinese laws against pyramid schemes, The New York Post reported last month, adding that the government had not said that it was investigating Herbalife. PRICE ACTION: In early trading, Nu Skin dropped over 3% to $80.02 and Herbalife sank 2.7% to $67.14. A third company in the sector, USANA Health Sciences (USNA), was fractionally lower at $57.51.
News For NUS;HLF;USNA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 2, 2015
13:44 EDTHLFHerbalife announces expansion plans for North Carolina facility
Subscribe for More Information
06:08 EDTHLFHerbalife implied volatility of 42 at lower end of index mean range
Subscribe for More Information
June 29, 2015
09:04 EDTHLFHerbalife says Eric D. Rosen will join company as VP of government relations
Herbalife announced that Eric D. Rosen will join Herbalife’s growing global corporate affairs team as VP of government relations and director of its Washington, D.C. office. Rosen will oversee Herbalife’s D.C. operations and will report to Ric Hobby, who was recently appointed as head of Herbalife’s global government relations reporting to Alan Hoffman, executive VP of the global corporate affairs team. Rosen, who will be based out of Herbalife’s D.C. office, is a Capitol Hill veteran with experience in the Senate, House, and Executive Branch.
June 26, 2015
13:09 EDTHLFPershing Square urges Herbalife CEO to release video referenced by NY Post
Pershing Square Capital released a letter it sent to Herbalife CEO Michael Johnson concerning his "serious admissions about Herbalife and its conduct that were revealed by the New York Post." The letter states in part: "Today the New York Post reported on a 71-minute video in which you appear on a stage, making serious admissions about Herbalife and its conduct...We urge that you release the 71-minute video and any similar materials in your possession or control, and we encourage Herbalife employees, distributors and others with similar materials to come forward...In February 2013, we publicly asked you to provide simple data on how many people arrive and leave at each level of Herbalife’s network over time...You still have not disclosed the facts. In light of your admission that Herbalife is a lottery ticket, basic fairness suggests you should disclose the facts."
10:00 EDTUSNAOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:56 EDTHLFVideo shows Herbalife CEO saw ‘pyramiding’ signs in 2005, NY Post reports
Subscribe for More Information
06:19 EDTUSNAUSANA initiated with a Buy at DA Davidson
Target $165.
June 25, 2015
10:07 EDTHLFHerbalife rises after Pivotal says SEC completes review of filings
Subscribe for More Information
09:47 EDTHLFHerbalife price target raised to $90 from $80 at Pivotal Research
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use